GCT-67 - Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

Publication date: 2019Source: European Urology Supplements, Volume 18, Issue 4Author(s): R.A. Huddart, F. Cafferty, J.D. White, J. Shamash, I. Hennig, M.H. Cullen, S.P. Stenning, for the TE23 Trial Management Group and Collaborators and the NCRI Testis Cancer Clinical Studies Group
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research